Morphological Differentiation of Oligodendrocytes Requires Activation of Fyn Tyrosine Kinase
Overview
Authors
Affiliations
In the central nervous system, myelination of axons occurs when oligodendrocyte progenitors undergo terminal differentiation and initiate process formation and axonal ensheathment. Although it is hypothesized that neuron-oligodendrocyte contact initiates this process, the molecular signals are not known. Here we find that Fyn tyrosine kinase activity is upregulated very early during oligodendrocyte progenitor cell differentiation. Concomitant with this increase is the appearance of several tyrosine phosphorylated proteins present only in differentiated cells. The increased tyrosine kinase activity is specific to Fyn, as other Src family members are not active in oligodendrocytes. To investigate the function of Fyn activation on differentiation, we used Src family tyrosine kinase inhibitors, PP1 and PP2, in cultures of differentiating oligodendrocyte progenitors. Treatment of progenitors with these compounds prevented activation of Fyn and reduced process extension and myelin membrane formation. This inhibition was reversible and not observed with related inactive analogues. A similar effect was observed when a dominant negative Fyn was introduced in progenitor cells. These findings strongly suggest that activation of Fyn is an essential signaling component for the morphological differentiation of oligodendrocytes.
Fyn, an important molecule in the brain, is a potential therapeutic target for brain tumours.
Xu C, Tang Y, Lu X, Chen R Front Pharmacol. 2024; 15:1485919.
PMID: 39697541 PMC: 11652172. DOI: 10.3389/fphar.2024.1485919.
Neonatal Brain Injury Triggers Niche-Specific Changes to Cellular Biogeography.
Tahmasian N, Feng M, Arbabi K, Rusu B, Cao W, Kukreja B eNeuro. 2024; 11(12).
PMID: 39681473 PMC: 11680506. DOI: 10.1523/ENEURO.0224-24.2024.
Emerging roles of oligodendrocyte precursor cells in neural circuit development and remodeling.
Buchanan J, da Costa N, Cheadle L Trends Neurosci. 2023; 46(8):628-639.
PMID: 37286422 PMC: 10524797. DOI: 10.1016/j.tins.2023.05.007.
Xing J, Lukomska A, Rheaume B, Kim J, Sajid M, Damania A Development. 2023; 150(8).
PMID: 36971369 PMC: 10163352. DOI: 10.1242/dev.201311.
Guan Z, Liang Y, Wang X, Zhu Z, Yang A, Li S Neurochem Res. 2022; 47(12):3709-3722.
PMID: 35960485 DOI: 10.1007/s11064-022-03717-7.